{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:08:14Z","timestamp":1792606094255,"version":"4.5.0"},"reference-count":17,"publisher":"American Chemical Society (ACS)","issue":"40","license":[{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Org. Lett."],"published-print":{"date-parts":[[2022,10,14]]},"DOI":"10.1021\/acs.orglett.2c02729","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T17:18:24Z","timestamp":1664558304000},"page":"7305-7308","source":"Crossref","is-referenced-by-count":11,"title":["Enabling Asymmetric Synthesis of ABBV-3748, a Corrector Compound for the Treatment of Cystic Fibrosis"],"prefix":"10.1021","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1993-2417","authenticated-orcid":true,"given":"Stephen N.","family":"Greszler","sequence":"first","affiliation":[{"name":"Research & Development, AbbVie, Inc., 1 N Waukegan Rd, North Chicago, Illinois 60064, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Research & Development, AbbVie, Inc., 1 N Waukegan Rd, North Chicago, Illinois 60064, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhadra","family":"Shelat","sequence":"additional","affiliation":[{"name":"Research & Development, AbbVie, Inc., 1 N Waukegan Rd, North Chicago, Illinois 60064, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9542-5356","authenticated-orcid":true,"given":"Eric A.","family":"Voight","sequence":"additional","affiliation":[{"name":"Research & Development, AbbVie, Inc., 1 N Waukegan Rd, North Chicago, Illinois 60064, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2022,9,30]]},"reference":[{"key":"ref1\/cit1a","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01662"},{"key":"ref1\/cit1b","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113195"},{"key":"ref1\/cit1c","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2020.07.015"},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.12.032"},{"key":"ref3\/cit3a","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b01339"},{"key":"ref3\/cit3b","doi-asserted-by":"publisher","DOI":"10.1021\/acs.orglett.9b02099"},{"key":"ref4\/cit4a","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.9b00377"},{"key":"ref4\/cit4b","doi-asserted-by":"publisher","DOI":"10.1021\/acs.joc.0c00820"},{"key":"ref4\/cit4c","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2022.128843"},{"key":"ref5\/cit5","unstructured":"Altenbach, R. J.; Bogdan, A.; Desroy, N.; Gfesser, G. A.; Greszler, S. N.; Kym, P. R.; Liu, B.; Malagu, K. F.; Merayo, N.; Pizzonero, M. R.; Searle, X. B.; Van Der Plas, S. E.; Wang, X.; Yeung, M. C. Preparation of sulfonyldihydrobenzopyrancarboxamide derivatives and analogs for use as cystic fibrosis transmembrane conductance regulator protein modulators. 2017, PCT Intl Appl. WO2018\/154493A1."},{"key":"ref6\/cit6","unstructured":"Boloor, A.; Chen, Y. K.; Wallace, M. B. Histone Demethylase Inhibitors. 2015, PCT\/US2015\/0378123."},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrev.5b00514"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1016\/j.tet.2003.05.003"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.1039\/C4OB02033B"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1021\/acs.oprd.9b00276"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1072739"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.1021\/acs.oprd.2c00245"}],"container-title":["Organic Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.orglett.2c02729","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.orglett.2c02729","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:23:42Z","timestamp":1682641422000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.orglett.2c02729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":17,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2022,10,14]]}},"alternative-id":["10.1021\/acs.orglett.2c02729"],"URL":"https:\/\/doi.org\/10.1021\/acs.orglett.2c02729","relation":{},"ISSN":["1523-7060","1523-7052"],"issn-type":[{"value":"1523-7060","type":"print"},{"value":"1523-7052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,30]]}}}